ROLL'YN-UST: an Observational Study in Patients Treated by Steqeyma®, an Ustekinumab Biosimilar
NCT06997055
·
clinicaltrials.gov ↗
RECRUITING
Status
225
Enrollment
INDUSTRY
Sponsor class
Conditions
Crohn Disease
Plaque Psoriasis
Interventions
DRUG:
Ustekinumab 45 mg
DRUG:
Ustekinumab 90 mg
Sponsor
Celltrion HealthCare France
Collaborators
[object Object]